My AML Patient Workshop Experience

November 28, 2023
Alan Katz

Alan Katz was diagnosed with Acute Myeloid Leukemia with a FLT3 mutation in November 2020 and had a bone marrow transplant in February 2021. Alan relapsed in May 2021 and had a Donor Lymphocyte Infusion in June 2021. He was able to get back into remission. He has been taking Xospata since his relapse and has continued to get better ever since. He has gone back to work part time and spends time taking care of his grandchildren. He also volunteers for various blood cancer advocacy groups.

Here's what I was asked during an AML patient workshop...

Recently, I participated in an Acute Myeloid Leukemia (AML) patient workshop sponsored by a pharmaceutical company. They hope to be running a clinical trial next year for a new therapy they are developing. Two of the questions they asked were thought provoking and they made me pause and think very hard.

The first question asked was, "What does it feel like living with AML?" Living with a cancer that has no cure and can easily recur is a huge burden. I always feel like there is a grand piano floating over my head. You can’t always see it but it is always there and you never know when it will come crashing down on your head. Instead of worrying about it falling on my head, I choose to look forward to a future full of good health and happiness.

The second question asked was, "What effect has AML had on my life?" The first thoughts that rushed through my mind were all negative. This cancer has stolen many of years of my life. I think about the negative toxic effects the chemo has had on my body as well as my mind.

When I pause and think for a few minutes, I realize that this cancer has also had some positive effects on my life, too. I have become a more caring and compassionate human being. It has brought my family closer together. I have more empathy for others who are suffering like myself. I also feel compelled to volunteer and help other AML patients who are currently going through the same things as I have already experienced.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.